Article
Video with Paul Pluta
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
PDA 2025: How Strategic CAPA Builds Anti-Fragile Manufacturing Compliance
FDA Enables Instant Access to CRLs—Insights for Drug Discovery and Manufacturing
Agentic AI Collaborative Initiative Announced by Pistoia Alliance
FDA Fast Track Designation for VMX-C001 Highlights Need for Improved Anticoagulant Reversal
New Year, Same Challenges: Pharma’s Ongoing Struggle with FDA 483s
FDA Approves Moderna’s Updated COVID-19 Vaccines Targeting LP.8.1 Variant